GTCR LLC holds a concentrated book of 6 stocks worth $3.8B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened GLOBAL PMTS INC and trimmed SOTERA HEALTH CO. Their largest long position is GLOBAL PMTS INC at 77% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1576350/holdings"
Use Arkolith to show GTCR LLC's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
6% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as GTCR LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| VANGUARD GROUP INC | 6 / 6 | $10.3B |
| BlackRock, Inc. | 6 / 6 | $5.8B |
| VANGUARD CAPITAL MANAGEMENT LLC | 6 / 6 | $4.8B |
| JPMORGAN CHASE & CO | 6 / 6 | $4.3B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6 / 6 | $3.5B |
| FMR LLC | 6 / 6 | $3.5B |
| STATE STREET CORP | 6 / 6 | $3.2B |
| GEODE CAPITAL MANAGEMENT, LLC | 6 / 6 | $1.9B |
Ranked by how many of GTCR LLC's top 6 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Global PMTS Inc COM | $2.9B | 43.27M | 77.0% | ▲New New position | |
| 2 | Gallagher Arthur J & Co COM | $514.1M | 2.37M | 13.6% | ▲New New position | |
| 3 | Sotera Health Co COM | $182.6M | 12.74M | 4.8% | ▼−44% Reduced · −10.0M sh | |
| 4 | Gogo Inc COM | $93.4M | 23.24M | 2.5% | —Held | |
| 5 | Maravai Lifesciences Hldgs I COM CL A | $57.0M | 20.15M | 1.5% | —Held | |
| 6 | Vivid Seats Inc COM CL A | $22.3M | 3.77M | 0.6% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 6 | $3.8B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 4 | $602.0M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 | 3 | $905.8M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 3 | $937.0M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 14, 2025 | 3 | $892.0M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 3 | $1.0B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 | 4 | $1.3B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 | 4 | $48.5B | 13F-HR/A |
| Q1 2024 | Mar 31, 2024 | May 14, 2024 | 3 | $1.2B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 3 | $1.6B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 | 3 | $1.6B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 11, 2023 | 3 | $2.1B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 12, 2023 | 3 | $2.0B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Jan 26, 2023 | 4 | $1.7B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 15, 2022 | 4 | $1.7B | 13F-HR/A |
| Q2 2022 | Jun 30, 2022 | Jul 19, 2022 | 4 | $2.8B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 | 4 | $3.2B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 11, 2022 | 4 | $3.3B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 1, 2021 | 4 | $3.9B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 5, 2021 | 4 | $3.6B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 5 | $3.5B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 5 | $4.0B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.